Literature DB >> 6154894

Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors.

V A Lennon, E H Lambert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154894     DOI: 10.1038/285238a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  30 in total

Review 1.  Immunopathologic events at the endplate in myasthenia gravis.

Authors:  T Ashizawa; S H Appel
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis.

Authors:  Chengyong Shen; Yisheng Lu; Bin Zhang; Dwight Figueiredo; Jonathan Bean; Jiung Jung; Haitao Wu; Arnab Barik; Dong-Min Yin; Wen-Cheng Xiong; Lin Mei
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

Review 3.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 4.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

5.  Autoimmune preganglionic sympathectomy induced by acetylcholinesterase antibodies.

Authors:  S Brimijoin; V A Lennon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 6.  Myasthenia gravis as a prototype autoimmune receptor disease.

Authors:  A C Hoedemaekers; P J van Breda Vriesman; M H De Baets
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

7.  Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection.

Authors:  Feng Lin; Henry J Kaminski; Bianca M Conti-Fine; Wei Wang; Chelliah Richmonds; M Edward Medof
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

8.  Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor.

Authors:  C M Gomez; R L Wollmann; D P Richman
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

9.  Neural autoantibody profile of primary achalasia.

Authors:  Robert E Kraichely; Gianrico Farrugia; Sean J Pittock; Donald O Castell; Vanda A Lennon
Journal:  Dig Dis Sci       Date:  2009-06-05       Impact factor: 3.199

10.  [Heterogeneity of acetylcholine receptor antibodies in patients with myasthenia gravis].

Authors:  I Kalies; F Heinz; W P Kaschka; K F Druschky; J R Kalden
Journal:  Klin Wochenschr       Date:  1984-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.